Inventor · disambiguated record
Robertson Towart
Also filed as: TOWART ROBERTSON
22 granted patents·2 pending applications·389 citations·filing 1977–2016
96Inventor score
Files withBAYER AG13NYCOMED IMAGING AS3PUGH RANDALL B3JOHNSON & JOHNSON VISION CARE2AMERSHAM HEALTH AS1
Top patents by PatentIndex Score
24 records- 0197US4532248AMethod of combatting coronary and vascular diseasesBAYER AG·Filed 1982·Granted Jul 30, 1985·109 cites·13 claims
- 0295US6391895B1Nitric oxide releasing chelating agents and their therapeutic useAMERSHAM HEALTH AS·Filed 2000·Granted May 21, 2002·64 cites·37 claims
- 0393US4248873ANitro-substituted 1,4-dihydropyridines, processes for _their production and their medicinal useBAYER AG·Filed 1978·Granted Feb 3, 1981·26 cites·11 claims
- 0487US4510310A1,4-Dihydro-2,6-dimethyl-4-(2'-chlorophenyl)-3,5-dicarboxylic acid,methyl or ethyl,trifluoroethyl esterBAYER AG·Filed 1982·Granted Apr 9, 1985·24 cites·2 claims
- 0583US4188395A1,4-Dihydropyridine derivatives substituted in the 2 position, and their use as medicamentsBAYER AG·Filed 1977·Granted Feb 12, 1980·20 cites·13 claims
- 0682US4177278A2-Alkyleneaminodihydropyridines compounds, their production and their medicinal useBAYER AG·Filed 1978·Granted Dec 4, 1979·18 cites·17 claims
- 0781US9248309B2Light therapy system including spectacle frames and contact lensesPUGH RANDALL B·Filed 2012·Granted Feb 2, 2016·21 cites·8 claims
- 0877US6310051B1Use of chelating agents in the treatment of atherosclerotic conditionsNYCOMED IMAGING AS·Filed 2000·Granted Oct 30, 2001·16 cites·15 claims
- 0974US4849433AThe compound, (⃡)1,4-dihydro-2,6-dimethyl-4-(2'-nitrophenyl)-pyridine-3,5-dicarboxylic acid, methyl isobutyl ester, compositions containing same and a method for effecting coronary dilationBAYER AG·Filed 1987·Granted Jul 18, 1989·13 cites·9 claims
- 1070US4988717AOptically active 1,4-dihydropyridine esters useful for treating circulatory illnessesBAYER AG·Filed 1989·Granted Jan 29, 1991·12 cites·11 claims
- 1167US4442100ASubstituted 2-amino-3,4-dihydropyridine derivatives, their production and their medicinal useBAYER AG·Filed 1980·Granted Apr 10, 1984·7 cites·14 claims
- 1266US4237137ASila-substituted 1,4-dihydropyridine derivatives and their medicinal useBAYER AG·Filed 1979·Granted Dec 2, 1980·11 cites·15 claims
- 1363US6147094AReduction of cardiotoxicity of an antitumor agent using manganese compoundNYCOMED IMAGING AS·Filed 1998·Granted Nov 14, 2000·18 cites·8 claims
- 1452US6342517B1Potassium channel activators and their useCAMBRIDGE BIOCLINICAL LTD·Filed 1999·Granted Jan 29, 2002·7 cites·25 claims
- 1551US6258828B1Chelating agents and their metal chelates for treating free radical induced conditionsNYCOMED IMAGING AS·Filed 1998·Granted Jul 10, 2001·12 cites·17 claims
- 1650US2016144149A1Light therapy system including spectacle frames and contact lensesJOHNSON & JOHNSON VISION CARE·Filed 2016·Application pending·0 cites
- 1747US4360520A1,4-Dihydropyridazine compounds, and their medicinal useBAYER AG·Filed 1978·Granted Nov 23, 1982·3 cites·13 claims
- 1847US4348395A1,4-Dihydropyridazine compoundsBAYER AG·Filed 1978·Granted Sep 7, 1982·3 cites·13 claims
- 1944US10384070B2Spectacles for light therapyJOHNSON & JOHNSON VISION CARE·Filed 2013·Granted Aug 20, 2019·0 cites·11 claims
- 2043US2012203310A1Spectacles for light therapyPUGH RANDALL B·Filed 2012·Application pending·0 cites
- 2141US4280998A1,4-Dihydropyridazine-3-carboxylic acid derivatives, a process for their preparation and their use as antihypertensivesBAYER AG·Filed 1979·Granted Jul 28, 1981·2 cites·14 claims
- 2239US9446262B2Apparatus and method for formation of an energized ophthalmic device for light therapyPUGH RANDALL B·Filed 2012·Granted Sep 20, 2016·0 cites·28 claims
- 2333US5627198AHeterocyclic amidesHAFSLUND NYCOMED PHARMA·Filed 1995·Granted May 6, 1997·2 cites·12 claims
- 2430US4680305AUse of sulphonyldihydropyridines as medicaments for the treatment of asthmaBAYER AG·Filed 1986·Granted Jul 14, 1987·1 cites·6 claims
Join the waitlist — get patent alerts
Get an alert when Robertson Towart files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →